This article contains some updated information as of February 24, 2023, since the publication of our previous article “Vaccination trends among China’s elderly from COVID-19 to flu: How to avoid a catastrophe.” This article was originally posted on Pharma Boardroom.
Elder receiving a COVID-19 vaccine shot in Shanghai, May 2022 | Source: Caixin January 5, 2023 | Stefania Jiang, Associate, Bridge Consulting As the COVID-19 outbreak escalates across China, one of the best solutions to protecting vulnerable populations from severe or fatal illness has been a renewed focus on vaccination campaigns. In early December 2022, as […]
mRNA prototype from CNBG at a Scientific and Technological Innovation Exhibition in China | Source: New York Times September 14, 2022 | Nandika Nair, 2022 Summer Intern, Bridge Consulting In this article, we touch upon: The advancement in China’s vaccine R&D over time and after the COVID-19 outbreak The development of Chinese vaccines based on more […]
A staff member of Sinopharm is handling the test vaccine samples | Source: China Daily September 6, 2022 | By Zoe Leung, Associate; Stefania Jiang, Junior Associate, Bridge Consulting What Happened? On 23 August 2022, the World Health Organization (WHO) announced that China’s National Regulatory Authority (NRA) for vaccines had reached a functional maturity level […]